Swiss National Bank Cabaletta Bio, Inc. Transaction History

Swiss National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$7.22 - $18.82 $52,706 - $137,386	7,300 Added 12.33%	66,500 $497,000
Q1 2024 May 07, 2024	BUY	$16.79 - $25.38 $137,678 - $208,116	8,200 Added 16.08%	59,200 $1.01 Million
Q4 2023 Feb 06, 2024	SELL	$12.21 - $23.36 $123,321 - $235,936	-10,100 Reduced 16.53%	51,000 $1.16 Million
Q3 2023 Nov 08, 2023	BUY	$11.84 - $18.65 $723,424 - $1.14 Million	61,100 New	61,100 $929,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.